Primary biliary cirrhosis--a revised clinical spectrum.

Area of Science:

• Hepatology
• Immunology
• Internal Medicine

Background:

• Primary biliary cirrhosis (PBC) is a chronic liver disease.
• Diagnosis often occurs incidentally through serological screening.
• Associated autoimmune conditions are common in PBC patients.

Purpose of the Study:

• To describe the presentation and detection methods of primary biliary cirrhosis (PBC) in a Northern England cohort.
• To evaluate the clinical outcomes and mortality of asymptomatic PBC patients.
• To explore the association of PBC with other autoimmune disorders.

Main Methods:

• Retrospective analysis of 93 patients diagnosed with PBC.
• Review of patient symptoms, liver function tests, and antimitochondrial antibody (AMA) titers.
• Assessment of liver histology and follow-up data on mortality and associated conditions.

Main Results:

• Nearly half of patients (45/93) were asymptomatic at diagnosis, with AMA detected during screening for other conditions.
• 13 patients with normal liver function tests had symptomless PBC, confirmed by histology and AMA positivity (≥1/40).
• Mortality in symptom-free, AMA-positive patients did not differ from the general population over a mean 4.5-year follow-up; only one such patient died.

Conclusions:

• Symptomless PBC detected via AMA screening is common.
• Many patients with asymptomatic PBC may not develop overt organ damage.
• PBC shares associations with other autoimmune diseases, suggesting a common underlying immunologic basis.